Outcomes of progranulin gene therapy in the retina are dependent on time and route of delivery.

Zin, Emilia A; Han, Daisy; Tran, Jennifer; Morisson-Welch, Nikolas; Visel, Meike; Kuronen, Mervi; Flannery, John G

Zin, Emilia A; Han, Daisy; Tran, Jennifer; Morisson-Welch, Nikolas; Visel, Meike; Kuronen, Mervi; Flannery, John G.

Afiliación

Zin EA; Vision Science Group, School of Optometry, UC Berkeley, Berkeley, CA 94720, USA.
Han D; Department of Integrative Biology, UC Berkeley, Berkeley, CA 94720, USA.
Tran J; School of Optometry, UC Berkeley, Berkeley, CA 94720, USA.
Morisson-Welch N; Helen Wills Neuroscience Institute, UC Berkeley, Berkeley, CA 94720, USA.
Visel M; Helen Wills Neuroscience Institute, UC Berkeley, Berkeley, CA 94720, USA.
Kuronen M; Helen Wills Neuroscience Institute, UC Berkeley, Berkeley, CA 94720, USA.
Flannery JG; Vision Science Group, School of Optometry, UC Berkeley, Berkeley, CA 94720, USA.

Mol Ther Methods Clin Dev ; 22: 40-51, 2021 Sep 10.

Article en En | MEDLINE | ID: mdl-34485593

Palabras clave

AAV; neuronal ceroid lipofuscinosis; progranulin; retina

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Ther Methods Clin Dev Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google